Crypto
Bitcoin ETFs Could Pave the Way for XRP and Ethereum ETFs
The approval of Bitcoin ETFs in the USA would have the potential to have a lasting impact on the crypto markets. Bitcoin would thus be officially recognized as a separate asset class – and leading altcoins would also be happy to claim such a status. The preparations for Ethereum ETFs are already well advanced, but approval is by no means guaranteed.
After the widely expected approval for Bitcoin ETFs, the markets are likely to start thinking about successors. In particular, XRP ETFs and those based on Ethereum (ETH) are in focus.
Wednesday, January 10th, could be a historic date for the crypto industry: The US Securities and Exchange Commission (SEC) is set to vote in New York on the approval of Bitcoin ETFs and it seems as if it will then abandon a blockade that has lasted for years. But if the SEC allows Bitcoin (BTC) to be traded through ETFs in a regulated environment, why shouldn’t the same be possible for other major cryptocurrencies?
It is known that the world’s largest asset manager BlackRock not only wants to launch a Bitcoin ETF, but has also already applied for an ETF based on Ethereum (ETH). When this became known in November 2023, Ethereum’s price curve jumped upwards. The SEC has now received several applications for Ethereum ETFs, but no decisions have been made yet.
Read more about the approval of crypto ETFs by SEC and find the most important financial news of the day with our companion app Born2Invest.
The desire to open up new markets through ETFs is also growing in the Ripple (XRP) community
The wide-reaching Ripple influencer JackTheRippler is already promoting an XRP ETF on X. A false report about the application for an XRP ETF in November cost investors in Ripple Futures billions.
In general, the SEC will probably have a harder time with XRP ETFs than with those based on Ethereum. Because Ripple and XRP are still being pursued legally by the SEC with the aim of strictly regulating institutional investments. With this history, the SEC will hardly have the nerve to wave through XRP ETFs. The chances for Ethereum ETFs in the USA could be better. Because the SEC has exempted Ethereum and Bitcoin from being classified as securities. When it comes to Ripple and XRP, the SEC insists on its deep reservations.
Conclusion: Bitcoin ETFs as a harbinger of the crypto revolution in the USA?
The approval of Bitcoin ETFs in the USA would have the potential to have a lasting impact on the crypto markets. Bitcoin would thus be officially recognized as a separate asset class – and leading altcoins would also be happy to claim such a status. The preparations for Ethereum ETFs are already well advanced, but approval is by no means guaranteed. There are many requests for XRP ETFs, even if the SEC hasn’t even received any applications yet. But this week all eyes are rightly on the SEC and Bitcoin ETFs.
__
(Featured image by Traxer via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in BLOCK-BUILDERS.DE. A third-party contributor translated and adapted the articles from the originals. In case of discrepancy, the originals will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us
-
Fintech1 week ago
Deutsche Bank Develops Layer 2 for Ethereum – With Extras for Authorities
-
Biotech2 weeks ago
Quirónsalud and Roche Farma Sign an Agreement to Promote Healthcare Innovation and Research
-
Business6 days ago
TopRanked.io Weekly Affiliate Digest: What’s Hot in Affiliate Marketing [1xBet Partner Program Review]
-
Biotech1 week ago
Novo Nordisk: Ozempic Gets Positive Evaluation for Kidney Treatment